World Health Organization Sounds Warning Over Severe Shortage of Obesity Jabs

Under 10% of patients eligible to benefit from weight-loss injections such as Wegovy are able to get them, states the global health agency as it issues its initial guidance on the medications.

Given more than one billion individuals worldwide currently classified as obese, it is urging broader and more equitable access to these injectable treatments.

According to estimates, in excess of 2,000,000,000 could be living with obesity by 2030 unless action is taken.

"The latest guidance affirms that obesity is a long-term condition that can be treated with holistic and continuous treatment," stated its chief Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and distribution challenges are key hurdles to widespread access to the injections that can assist patients in reducing significant weight, explains the body.

Skinny Jab Supply Crisis

Even under the present most favorable scenario, the manufacturing of GLP-1 therapies would only suffice for about 100 million people – fewer than 10% of those who need them, as stated by the WHO.

The recommendation urges nations and manufacturers to increase access, via strategies including licensing agreements.

The intellectual property rights on a key compound – the primary component of Novo Nordisk's Wegovy – is scheduled to end in several countries in 2026.

How Weight-Loss Drugs Operate

The injections imitate a biological compound to delay gastric emptying, curb appetite and enhance the sense of being full so users eat less.

Individuals usually start to lose weight within a few weeks of starting on the regular doses.

Research indicates people may see weight return after a year of stopping the treatment, because their typical hunger resume.

To be carrying excess weight increases your chance for contracting diseases, such as type 2 diabetes, cardiovascular issues, stroke, and specific malignancies.

Obesity impacts people in countries worldwide and was linked to over three and a half million deaths worldwide in 2024, as per the health agency.

Michael Yang
Michael Yang

Award-winning journalist with over 15 years of experience covering UK politics and international affairs, known for her investigative reporting.